Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
DITEKIREN
ID: ALA1790497
Max Phase: Phase
Molecular Formula: C50H75N9O8
Molecular Weight: 930.20
Molecule Type: Small molecule
Associated Items:
ID: ALA1790497
Max Phase: Phase
Molecular Formula: C50H75N9O8
Molecular Weight: 930.20
Molecule Type: Small molecule
Associated Items:
Synonyms (2): MCMC-6317 | U-71038
Synonyms from Alternative Forms(2):
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(C)C)C(=O)NCc1ccccn1
Standard InChI: InChI=1S/C50H75N9O8/c1-11-33(6)43(47(64)53-29-35-20-15-16-22-52-35)57-44(61)37(32(4)5)27-42(60)38(24-31(2)3)55-46(63)41(26-36-28-51-30-54-36)58(10)48(65)39(25-34-18-13-12-14-19-34)56-45(62)40-21-17-23-59(40)49(66)67-50(7,8)9/h12-16,18-20,22,28,30-33,37-43,60H,11,17,21,23-27,29H2,1-10H3,(H,51,54)(H,53,64)(H,55,63)(H,56,62)(H,57,61)/t33-,37-,38-,39-,40-,41-,42-,43-/m0/s1
Standard InChI Key: SASWSEQJAITMKS-JJNNLWIXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 930.20 | Molecular Weight (Monoisotopic): 929.5739 | AlogP: 4.70 | #Rotatable Bonds: 23 |
Polar Surface Area: 228.05 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.06 | CX Basic pKa: 6.53 | CX LogP: 4.10 | CX LogD: 4.05 |
Aromatic Rings: 3 | Heavy Atoms: 67 | QED Weighted: 0.08 | Np Likeness Score: -0.27 |
1. Thaisrivongs S, Pals DT, Harris DW, Kati WM, Turner SR.. (1986) Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo., 29 (10): [PMID:3531518] [10.1021/jm00160a049] |
2. Epps DE, Poorman RA, Mandel F, Schostarez HJ.. (1991) Determination of dissociation constants of high affinity (pM) human renin inhibitors: application to analogues of ditekiren (U-71,038)., 34 (7): [PMID:2066983] [10.1021/jm00111a028] |
3. Sawyer TK, Pals DT, Mao B, Staples DJ, de Vaux AE, Maggiora LL, Affholter JA, Kati W, Duchamp D, Hester JB.. (1988) Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions., 31 (1): [PMID:3275777] [10.1021/jm00396a006] |
4. Takahashi H, Kim RB, Perry PR, Wilkinson GR.. (1997) Characterization of the hepatic canalicular membrane transport of a model oligopeptide: ditekiren., 281 (1): [PMID:9103510] |
5. Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD.. (2000) Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein., 57 (1): [PMID:10617675] |
6. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
Source(3):